Efficacy and Safety of Renal Function on Edoxaban Versus Warfarin for Atrial Fibrillation: A Systematic Review and Meta-Analysis
<b>Background</b>: Edoxaban is a novel oral anticoagulant which may decrease the risk of stroke and systemic embolism in patients suffering from atrial fibrillation (AF). However, the decreased efficacy of edoxaban versus warfarin for the avoidance of stroke and systemic embolism in AF with creatini...
Spremljeno u:
| Glavni autori: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2023-01-01
|
| Serija: | Medicines |
| Teme: | |
| Online pristup: | https://www.mdpi.com/2305-6320/10/1/13 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|